EMERYVILLE, Calif.,
Feb. 9, 2022 /PRNewswire/ -- Amyris,
Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company
accelerating the world's transition to sustainable consumption
through its Lab-to-Market™ operating platform today announced that
it has closed the acquisition of EcoFabulous, a Gen Z-focused clean
beauty consumer brand. Amyris also announced the start of
production of a range of consumer products at the Reno, Nevada facility ahead of its mid-year
schedule.
Consistent with its 2022 communicated plan to launch a new Gen-Z
clean beauty offering, Amyris has completed the acquisition of
EcoFabulous cosmetics. EcoFabulous is a brand dedicated to
providing Gen Z consumers affordably priced skin care and color
cosmetics with an emphasis on sustainability, product performance
and efficacy. Amyris expects sales to begin during the third
quarter of 2022 through its direct-to-consumer ecommerce platform
and retail partnerships. The acquisition furthers Amyris' growth
and market leadership in clean beauty and complements Amyris'
family of consumer brands.
The transition to the consumer production plant in Reno is an important first step in Amyris'
strategy to consolidate manufacturing capabilities across its
growing family of consumer brands. It reduces Amyris' reliance on
third party manufacturing, enhances control over its supply chain
and is expected to result in lower unit costs of its consumer
products.
"We are very pleased with the addition of EcoFabulous to our
family of consumer brands," said John
Melo, President and Chief Executive Officer of Amyris. "Our
consumer growth is accelerating due to the early success of our
recently launched brands, Rose Inc. and JVN, along with the
continued momentum of Biossance, Pipette and Purecane. We have also
successfully brought forward production in Reno, Nevada which will support our consumer
product growth. The first consumer products will be produced this
quarter ahead of our previously communicated mid-year 2022 target.
We continue to execute well across our business and expect the
first quarter to be our strongest consumer revenue quarter
yet."
About Amyris
Amyris (Nasdaq: AMRS) is a leading
synthetic biotechnology company, transitioning the Clean Health
& Beauty and Flavors & Fragrances markets to sustainable
ingredients through fermentation and the company's proprietary
Lab-to-Market™ operating platform. This Amyris platform leverages
state-of-the-art machine learning, robotics and artificial
intelligence, enabling the company to rapidly bring new innovation
to market at commercial scale. Amyris ingredients are included in
over 20,000 products from the world's top brands, reaching more
than 300 million consumers. Amyris also owns and operates a family
of consumer brands that is constantly evolving to meet the growing
demand for sustainable, effective and accessible products. For more
information, please visit http://www.amyris.com.
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
Forward-Looking Statements
This release contains
forward-looking statements, and any statements other than
statements of historical fact could be deemed to be forward-looking
statements. These forward-looking statements include, among other
things, statements regarding future events, such as the expectation
of EcoFabulous sales to begin in the third quarter of 2022 and that
the acquisition of EcoFabulous will further Amyris' growth and
market leadership in clean beauty; the expected benefits of
commencing manufacturing at the Reno consumer product plant and the timing
thereof; and Amyris' expectations regarding accelerated consumer
growth due to early success of its recently launched consumer
brands, including that the first quarter of 2022 will be Amyris'
strongest consumer revenue quarter to date. These statements are
based on management's current expectations and actual results and
future events may differ materially due to risks and uncertainties,
including risks related to the Amyris' liquidity and ability to
fund operating and capital expenses, risks related to potential
delays or failures in completing and integrating planned
acquisitions, risks related to potential delays or failures in
development, regulatory approval, launch, production and
commercialization of products, risks related to the COVID-19
pandemic and resulting global economic, financial and supply chain
disruptions that may negatively impact Amyris' business operations
and financial results, risks related to reliance on third parties,
and other risks detailed from time to time in filings Amyris makes
with the Securities and Exchange Commission, including Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current
Reports on Form 8-K. The companies disclaim any obligation to
update information contained in these forward-looking statements,
whether as a result of new information, future events, or
otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amyris-closes-ecofabulous-transaction-and-commences-production-of-consumer-products-in-reno-nevada-plant-301478435.html
SOURCE Amyris, Inc.